Enterprise Financial Services Corp
Change company Symbol lookup
Select an option...
EFSC Enterprise Financial Services Corp
CYPS Cyclo3pss Corp
CXW CoreCivic Inc
STM STMicroelectronics NV
NYT New York Times Co
SOS Sos Ltd
DDOC DERMADOCTOR, INC.
CLOV Clover Health Investments Corp
POL Polished.Com Inc
ENJYQ Legacy EJY Inc
Go

Financials : Banks | Small Cap Blend
Company profile

Enterprise Financial Services Corp (EFSC) is the holding company for Enterprise Bank & Trust (the Bank). The Bank offers banking and wealth management services to individuals and corporate customers across Arizona, California, Kansas, Missouri, Nevada and New Mexico. Its business objective is to generate attractive shareholder returns by providing comprehensive financial services primarily to privately-held businesses, their owner families, and other success-minded individuals. The Company offers a range of business and personal banking services, including wealth management services. Its lending services include commercial and industrial (C&I), commercial real estate (CRE), real estate construction and development, residential real estate, small business administration (SBA), and consumer and tax credit-related loan products. It offers a range of deposit products and a suite of treasury management and international trade services, along with its tax credit brokerage activities.

Closing Price
$51.78
Day's Change
-0.27 (-0.52%)
Bid
--
Ask
--
B/A Size
--
Day's High
52.08
Day's Low
51.50
Volume
(Below Average)
Volume:
79,659

10-day average volume:
96,254
79,659

Moderna Inc. Stock Underperforms Thursday When Compared To Competitors

4:32 pm ET September 29, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Moderna Inc. (MRNA) slid 3.34% to $118.07 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.84% to 10,737.51 and Dow Jones Industrial Average falling 1.54% to 29,225.61. This was the stock's second consecutive day of losses. Moderna Inc. closed $272.53 below its 52-week high ($390.60), which the company achieved on September 30th.

The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. (ABBV) fell 1.30% to $142.72, Amgen Inc. (AMGN) fell 1.11% to $228.41, and AstraZeneca PLC ADR (AZN.LN) rose 0.40% to $54.91. Trading volume (4.7 M) remained 32,345 below its 50-day average volume of 4.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 29, 2022.

	

(END) Dow Jones Newswires

September 29, 2022 16:32 ET (20:32 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.